Cystic Fibrosis

Lung organoid

UNSW researchers are leading a revolutionary approach to managing treatment of cystic fibrosis using patients’ derived lung and gut mini-organs or ‘avatars’ to test how they will respond to the latest drugs.

unsw_med_54_keith_ooi.jpg

UNSW medical researcher Keith Ooi has received a $1 million grant to lead a major study to see if probiotics can improve the overall health and life expectancy of children with cystic fibrosis.